Novavax SG&A Expense (Quarterly) Insights

Novavax Inc (NVAX)

4.755 -0.18 (-3.55%) USD | NASDAQ | May 06, 16:00

4.63 -0.12 (-2.63%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	155.24M
September 30, 2023	107.46M
June 30, 2023	93.72M
March 31, 2023	112.53M
December 31, 2022	161.66M
September 30, 2022	122.88M
June 30, 2022	108.16M
March 31, 2022	95.99M
December 31, 2021	84.21M
September 30, 2021	77.79M
June 30, 2021	73.16M
March 31, 2021	63.19M
December 31, 2020	61.31M
September 30, 2020	56.88M
June 30, 2020	17.72M
March 31, 2020	9.379M
December 31, 2019	8.181M
September 30, 2019	7.899M
June 30, 2019	9.606M
March 31, 2019	8.732M
December 31, 2018	9.224M
September 30, 2018	8.309M
June 30, 2018	8.224M
March 31, 2018	8.652M
December 31, 2017	8.54M

Date	Value
September 30, 2017	8.118M
June 30, 2017	8.94M
March 31, 2017	8.852M
December 31, 2016	8.344M
September 30, 2016	13.56M
June 30, 2016	14.10M
March 31, 2016	10.53M
December 31, 2015	8.851M
September 30, 2015	9.06M
June 30, 2015	7.088M
March 31, 2015	5.843M
December 31, 2014	5.057M
September 30, 2014	4.757M
June 30, 2014	5.806M
March 31, 2014	4.308M
December 31, 2013	4.079M
September 30, 2013	3.857M
June 30, 2013	4.012M
March 31, 2013	2.87M
December 31, 2012	2.472M
September 30, 2012	2.134M
June 30, 2012	2.469M
March 31, 2012	2.985M
December 31, 2011	1.974M
September 30, 2011	2.737M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

7.899M

Minimum

Sep 2019

161.66M

Maximum

Dec 2022

75.10M

Average

77.79M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks